Faculty profile

Sorana Morrissy

ResearcherMedicineUniversity of Calgary

This profile is built from public research funding records (CIHR, NSERC and SSHRC) and PubMed. We have not imported them from a University of Calgary directory, so their courses and email address may be missing. Find their university profile.

Sorana Morrissy

Researcher

Medicine

Health Sciences

University of Calgary

Calgary, Alberta, Canada

Supervision signals

Has led research grants, which requires an independent research appointment. Ask their department whether they supervise graduate students.
8 publications in the last five years, latest in 2026.
Senior (last) author on 1 recent paper, a sign of leading a research group.
Principal investigator on 4 research grants (4 CIHR), most recently in 2024.
Supervisor on 1 trainee award (1 CIHR), most recently in 2025.

These signals come from public records, including CIHR, NSERC and SSHRC funding decisions. Ask the professor or the graduate program whether they are taking new students.

Academic metrics

Publications

Citations

Collaborators

Grants

Publications by year

Counts cover the publications linked to this profile. Citations and the h-index appear when the source records them.

Profiles and links

Search on Google Scholar

Find them onX · LinkedIn · Bluesky · YouTube

Signals and details

Research

Alveolar Soft Part Sarcoma Car T Immunotherapy Renal Cell Carcinoma Sarcoma Triple-Negative Breast Cancer Brain Tumor Research Crc

Latest papers

Compound delivery of eVLPs enhances prime editing for targeted genome engineering and high-throughput screening.
Cell genomics · 2026
Development and computational analysis of high dimensional spectral flow cytometry data for the resolution of innate lymphoid cells in the mammary tumor microenvironment.
Frontiers in immunology · 2026
ZIC1 is a context-dependent medulloblastoma driver in the rhombic lip
Nature Genetics · 2025

All 13 publications

Latest funding

Conditioning the Tumor and Empowering the Cell: A New Paradigm for CAR T Therapy in Soft Tissue Sarcomas
CIHR · 2026 · Co-investigator
$1,181,926
Characterizing the role of type 2 innate lymphoid cells in PD-1 blockade therapy
CIHR · 2025 · Co-investigator
$1,201,050
Developing novel chimeric antigen receptor double-negative T-cell therapy for acute myeloid leukemia
CIHR · 2025 · Supervisor
$140,000

All 9 grants and awards

13 publications.

Compound delivery of eVLPs enhances prime editing for targeted genome engineering and high-throughput screening.

Langley J, Baudrier L, Curry J, Narta K, Todesco HM, Potts K, Morrissy S, Mahoney DJ, Billon P

Cell genomics2026

DOI: 10.1016/j.xgen.2026.101302 PMID: 42447864

Development and computational analysis of high dimensional spectral flow cytometry data for the resolution of innate lymphoid cells in the mammary tumor microenvironment.

Seo H, Xue J, Huang Q, Kinzel M, Verma A, Huynh N, Jamila Ikra Z, Mahoney DJ, Lee J, Morrissy S, Jacquelot N

Frontiers in immunology2026

DOI: 10.3389/fimmu.2026.1730567 PMID: 41676157

ZIC1 is a context-dependent medulloblastoma driver in the rhombic lip

Lee JJY, Tao R, You Z, Haldipur P, Erickson AW, Farooq H, Hendriske LD, Abeysundara N, Richman CM, Wang EY

Nature Genetics202513 citationsOpen Access

DOI: 10.1038/s41588-024-02014-z PMID: W4406034886

Spatial and Single-Cell Transcriptomics Reveal that Oncofetal Reprogramming of Fibroblasts Is Associated with Malignant Degeneration of Burn Scar.

Sinha S, Arora R, Kutluberk E, Verly M, Small C, Herik A, Burnett L, Cao L, Manoharan VT, Chockalingam K, van der Vyver M, Ponjevic D, Sparks HD, Morrissy S, Harrop AR, Brenn T, Nikolic A, Temple-Oberle C, Rosin N, Gabriel V, Biernaskie J

The Journal of investigative dermatology2025

DOI: 10.1016/j.jid.2024.07.022 PMID: 39128494

mosaicMPI: a framework for modular data integration across cohorts and -omics modalities.

Verhey TB, Seo H, Gillmor A, Thoppey-Manoharan V, Schriemer D, Morrissy S

Nucleic acids research2024Senior author

DOI: 10.1093/nar/gkae442 PMID: 38813827

Characterization of innate lymphoid cell subsets infiltrating melanoma and epithelial ovarian tumors.

Chung DC, Ghaedi M, Warner K, Sayad A, Saibil SD, Bernardini MQ, Clarke BA, Shaw PA, Butler MO, Easson A, Morrissy S, Wang BX, Nguyen L, Ohashi PS, Jacquelot N

Oncoimmunology2024

DOI: 10.1080/2162402x.2024.2349347 PMID: 38746870

Mouse Model of Fragile X Syndrome Analyzed by Quantitative Proteomics: A Comparison of Methods.

Filandrova R, Douglas P, Zhan X, Verhey TB, Morrissy S, Turner RW, Schriemer DC

Journal of proteome research2023

DOI: 10.1021/acs.jproteome.3c00363 PMID: 37595185

The proteomic landscape of glioblastoma recurrence reveals novel and targetable immunoregulatory drivers

Tatari N, Khan S, Livingstone J, Zhai K, Mckenna D, Ignatchenko V, Chokshi C, Gwynne WD, Singh M, Revill S

Acta Neuropathologica202237 citations

DOI: 10.1007/s00401-022-02506-4

Copy-scAT: Deconvoluting single-cell chromatin accessibility of genetic subclones in cancer.

Nikolic A, Singhal D, Ellestad K, Johnston M, Shen Y, Gillmor A, Morrissy S, Cairncross JG, Jones S, Lupien M, Chan JA, Neri P, Bahlis N, Gallo M

Science advances2021

DOI: 10.1126/sciadv.abg6045 PMID: 34644115

Histology-based molecular profiling improves mutation detection for advanced thyroid cancer.

Eszlinger M, Khalil M, Gillmor AH, Huang H, Stewardson P, McIntyre JB, Morrissy S, Paschke R

Genes, chromosomes & cancer2021

DOI: 10.1002/gcc.22949 PMID: 33749950

Conditioning the Tumor and Empowering the Cell: A New Paradigm for CAR T Therapy in Soft Tissue Sarcomas

Co-investigatorCIHR2026Project Grant

Principal investigators: Monument, Michael J

Keywords: Car T Immunotherapy; Mouse Models; Sarcoma; Single Cell Rna Sequencing; Sting Immunotherapy; Tumor Radiation

$1,181,926

Characterizing the role of type 2 innate lymphoid cells in PD-1 blockade therapy

Co-investigatorCIHR2025Project Grant

Principal investigators: Jacquelot, Nicolas

Keywords: Anti-Pd-1 Antibody; Combination Treatment; Ilc2s; Immunotherapy; Innate Immunity; Innate Lymphoid Cells; Tumour Immunology

$1,201,050

Developing novel chimeric antigen receptor double-negative T-cell therapy for acute myeloid leukemia

SupervisorCIHR2025Canada Postdoctoral Research Award (CPRA) program

Principal investigators: Tin, Enoch

Keywords: Acute Myeloid Leukemia; Adoptive Cellular Therapy; Cancer Immunotherapy; Chimeric Antigen Receptor-T Cell Therapy; Double-Negative T Cells; Single-Cell Rna Sequencing; Xenograft Mouse Models

$140,000

Canada Research Chair - Tier 2

Nominated PICIHR2024Canada Research Chairs - CIHR Funded - Tier 2

Principal investigators: Morrissy, Sorana A

Keywords: Cr

$500,000

The Pan-Canadian Genome Library (PCGL)

Co-investigatorCIHR2023Team Grant: Pan-Canadian Human Genome Library

Principal investigators: Bourque, Guillaume; Boycott, Kym M; Scherer, Stephen W; Bhérer, Claude; Brazas, Michelle D; Brudno, Michael; Caron, Nadine R; Courtot, Mélanie; Ferretti, Vincent; Joly, Yann; Jones, Steven; Lerner-Ellis, Jordan P; Stedman, Ian; Stein, Lincoln; Wasserman, Wyeth W; Zawati, Ma'n Hilmi M.

Keywords: Clinical Trials; Data Diversity; Data Standards; Database; Federated Network; Genetic Variants; Genetics; Genomics; Human Genomes; Portals

$14,940,000

A Phase I Feasibility and Safety Study of GCAR1, a Chimeric Antigen Receptor (CAR) T-cell Therapy for Patients with Relapsed/Refractory GPNMB-Expressing Solid Tumors

Principal investigatorCIHR2023Project Grant

Principal investigators: Shafey, Mona; Abdul Razak, Albiruni R; Hay, Kevin A; Henning, Jan-Willem; Kekre, Natasha; Mahoney, Douglas J; Morrissy, Sorana A; Noujaim, Jonathan; Simmons, Christine E

Keywords: Alveolar Soft Part Sarcoma; Car T; Immunotherapy; Renal Cell Carcinoma; Sarcoma; Triple-Negative Breast Cancer

$2,796,075

Proteogenomic profiling of heterogeneity in glioblastoma

Nominated PICIHR2020Project Grant

Principal investigators: Morrissy, Sorana A

Keywords: Brain Tumor Research

$780,301

High-Throughput Analysis of Low Dose, Repetitive Alpha Particle Irradiation as a source of Radon-Induced Lung Cancer

Co-investigatorCIHR2020Project Grant

Principal investigators: Goodarzi, Aaron

Keywords: Alpha Particle; Dna Damage; Dna Repair; Genome Stability; Ionizing Radiation; Lung Cancer; Mutagenesis; Radon

$940,950

Canada Research Chair Tier 2

Nominated PICIHR2018Canada Research Chairs - CIHR Funded - Tier 2

Principal investigators: Morrissy, Sorana A

Keywords: Crc

$500,000

From CIHR, NSERC and SSHRC funding decisions: CIHR since 2008, NSERC since 1991 and SSHRC since 1998, including their latest published competition results.

Something wrong or missing on this profile? Suggest a correction

Sorana Morrissy

Research

Latest papers

Latest funding

Compound delivery of eVLPs enhances prime editing for targeted genome engineering and high-throughput screening.

Development and computational analysis of high dimensional spectral flow cytometry data for the resolution of innate lymphoid cells in the mammary tumor microenvironment.

ZIC1 is a context-dependent medulloblastoma driver in the rhombic lip

Spatial and Single-Cell Transcriptomics Reveal that Oncofetal Reprogramming of Fibroblasts Is Associated with Malignant Degeneration of Burn Scar.

mosaicMPI: a framework for modular data integration across cohorts and -omics modalities.

Characterization of innate lymphoid cell subsets infiltrating melanoma and epithelial ovarian tumors.

Mouse Model of Fragile X Syndrome Analyzed by Quantitative Proteomics: A Comparison of Methods.

The proteomic landscape of glioblastoma recurrence reveals novel and targetable immunoregulatory drivers

Copy-scAT: Deconvoluting single-cell chromatin accessibility of genetic subclones in cancer.

Histology-based molecular profiling improves mutation detection for advanced thyroid cancer.

Frequent collaborators

Mathieu Lupien

Nicolas Jacquelot

Sheila Singh

Nizar Bahlis

Marco Gallo

David Schriemer

Alexandra Easson

Pierre Billon

Thomas Kislinger

Stephane Angers

Gelareh Zadeh

Cynthia Hawkins

Nada Jabado

Vijay Ramaswamy

Jeffrey Greenspoon

Chi-Chung Hui

Jennifer Chan

Jason Moffat

Steven Jones

Livia Garzia

Hong Han

Kjetil Ask